159 related articles for article (PubMed ID: 32728167)
1. NHF-derived carbon dots: prevalidation approach in breast cancer treatment.
Tiron CE; Luta G; Butura M; Zugun-Eloae F; Stan CS; Coroaba A; Ursu EL; Stanciu GD; Tiron A
Sci Rep; 2020 Jul; 10(1):12662. PubMed ID: 32728167
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Anti-Tumoral Potential of CD-NHF by Modulating PI3K/Akt Axis in U87 Ex Vivo Glioma Model.
Luta G; Butura M; Tiron A; Tiron CE
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918086
[TBL] [Abstract][Full Text] [Related]
3. Entrapment of
Savin CL; Tiron C; Carasevici E; Stan CS; Ibanescu SA; Simionescu BC; Peptu CA
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31266139
[TBL] [Abstract][Full Text] [Related]
4. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
[TBL] [Abstract][Full Text] [Related]
5. The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model.
Ye T; Xiong Y; Yan Y; Xia Y; Song X; Liu L; Li D; Wang N; Zhang L; Zhu Y; Zeng J; Wei Y; Yu L
PLoS One; 2014; 9(1):e85887. PubMed ID: 24416452
[TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Chen YA; Chiou YS; Ho SY; Lin P; Wang YJ
PLoS One; 2013; 8(10):e76340. PubMed ID: 24130769
[TBL] [Abstract][Full Text] [Related]
7. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
[TBL] [Abstract][Full Text] [Related]
8. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
McClements L; Annett S; Yakkundi A; O'Rourke M; Valentine A; Moustafa N; Alqudah A; Simões BM; Furlong F; Short A; McIntosh SA; McCarthy HO; Clarke RB; Robson T
BMC Cancer; 2019 Apr; 19(1):351. PubMed ID: 30975104
[TBL] [Abstract][Full Text] [Related]
9. The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.
Garona J; Pifano M; Orlando UD; Pastrian MB; Iannucci NB; Ortega HH; Podesta EJ; Gomez DE; Ripoll GV; Alonso DF
Int J Oncol; 2015; 46(6):2335-45. PubMed ID: 25846632
[TBL] [Abstract][Full Text] [Related]
10. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling.
Li J; Hu L; Zhou T; Gong X; Jiang R; Li H; Kuang G; Wan J; Li H
Life Sci; 2019 Sep; 232():116617. PubMed ID: 31260685
[TBL] [Abstract][Full Text] [Related]
11. Hinokiflavone induces apoptosis and inhibits migration of breast cancer cells via EMT signalling pathway.
Huang W; Liu C; Liu F; Liu Z; Lai G; Yi J
Cell Biochem Funct; 2020 Apr; 38(3):249-256. PubMed ID: 32107809
[TBL] [Abstract][Full Text] [Related]
12. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
[TBL] [Abstract][Full Text] [Related]
14. Cimicifuga dahurica extract inhibits the proliferation, migration and invasion of breast cancer cells MDA-MB-231 and MCF-7 in vitro and in vivo.
Jia H; Wang X; Liu W; Qin X; Hu B; Ma Q; Lv C; Lu J
J Ethnopharmacol; 2021 Sep; 277():114057. PubMed ID: 33771643
[TBL] [Abstract][Full Text] [Related]
15. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
16. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
[TBL] [Abstract][Full Text] [Related]
17. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
Tilli TM; Carels N; Tuszynski JA; Pasdar M
Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
[TBL] [Abstract][Full Text] [Related]
18. Suppression of MD2 inhibits breast cancer in vitro and in vivo.
Zheng S; Fu W; Ma R; Huang Q; Gu J; Zhou J; Lu K; Guo G
Clin Transl Oncol; 2021 Sep; 23(9):1811-1817. PubMed ID: 33733435
[TBL] [Abstract][Full Text] [Related]
19. N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells.
Wang M; Zhou A; An T; Kong L; Yu C; Liu J; Xia C; Zhou H; Li Y
J Exp Clin Cancer Res; 2016 Mar; 35():41. PubMed ID: 26940018
[TBL] [Abstract][Full Text] [Related]
20. Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis.
Yin SY; Jian FY; Chen YH; Chien SC; Hsieh MC; Hsiao PW; Lee WH; Kuo YH; Yang NS
Nat Commun; 2016 Apr; 7():11311. PubMed ID: 27089063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]